February 2019 Briefing – Family Practice

Here are what the editors at HealthDay consider to be the most important developments in Family Practice for February 2019. This roundup includes the latest research news from journal articles, […]

Here are what the editors at HealthDay consider to be the most important developments in Family Practice for February 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.

Teens’ Social Media Use Does Not Predict Later Depression

THURSDAY, Feb. 28, 2019 (HealthDay News) — Social media use does not predict later depressive symptoms among adolescents or college undergraduates, according to a study recently published in Clinical Psychological Science.

Abstract/Full Text (subscription or payment may be required)

FDA: Pulmonary Embolism Risk Up With Tofacitinib 10 mg for RA

THURSDAY, Feb. 28, 2019 (HealthDay News) — A safety clinical trial has revealed that tofacitinib (Xeljanz, Xeljanz XR) 10 mg twice daily is associated with an increased risk for pulmonary embolism (PE) and death among patients with rheumatoid arthritis (RA), the U.S. Food and Drug Administration warned in a safety alert this week.

More Information

Flu Vaccination During Pregnancy Does Not Cause Miscarriage

THURSDAY, Feb. 28, 2019 (HealthDay News) — An influenza vaccine cannot cause a pregnant woman to miscarry, researchers say.

CNN Article
More Information

Dietary Monitoring Key to Successful Weight Loss

THURSDAY, Feb. 28, 2019 (HealthDay News) — The frequency of dietary self-monitoring is significantly associated with weight loss, according to a study published online Feb. 25 in Obesity.

Abstract/Full Text

CDC: Progress in HIV Prevention Has Stalled in the United States

WEDNESDAY, Feb. 27, 2019 (HealthDay News) — The battle against new HIV infections has lost some steam in recent years, according to the U.S. Centers for Disease Control and Prevention.

More Information

Lowering BP, Lipids in Healthy Elderly Has No Cognitive Effect

WEDNESDAY, Feb. 27, 2019 (HealthDay News) — Candesartan plus hydrochlorothiazide, rosuvastatin, or their combination do not impact cognitive decline among older people, according to a study published online Feb. 27 in Neurology.

Abstract/Full Text (subscription or payment may be required)

Prenatal Vitamin Intake in Early Pregnancy May Cut Autism Risk

WEDNESDAY, Feb. 27, 2019 (HealthDay News) — Maternal prenatal vitamin intake during the first month of pregnancy is associated with a reduced risk for autism spectrum disorder (ASD) in siblings of children with ASD, according to a study published online Feb. 27 in JAMA Psychiatry.

Abstract/Full Text (subscription or payment may be required)

Achievement of Targets in T2DM Varies by Season

WEDNESDAY, Feb. 27, 2019 (HealthDay News) — There is seasonal variation in achievement of the guideline targets for hemoglobin A1c (HbA1c), blood pressure (BP), and low-density lipoprotein (LDL) cholesterol among persons with type 2 diabetes mellitus (T2DM), according to a study published online Feb. 22 in Diabetes Care.

Abstract/Full Text (subscription or payment may be required)

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19
Page 1 of 19
Next »